The role of inflammation and liver cancer (Q38211088)

31 August 2017

The role of inflammation and liver cancer (English)

1 reference

31 August 2017

Anupam Bishayee

1

1 reference

PubMed ID

24818732

31 August 2017

language of work or name

English

0 references

publication date

1 January 2014

1 reference

Advances in Experimental Medicine and Biology

31 August 2017

1 reference

31 August 2017

816

1 reference

31 August 2017

401-435

1 reference

NF-κB in cancer: a matter of life and death

31 August 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Immunohistochemical localization of inducible nitric oxide synthase and 3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Nuclear factor-kappa B as a promising target for selenium chemoprevention in rat hepatocarcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Molecular mechanisms of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Cellular and molecular mechanisms of hepatocellular carcinoma: an update

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Anti-inflammatory plant natural products for cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Nuclear factor-kappaB and liver carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

New therapies for hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

MicroRNAs: genomics, biogenesis, mechanism, and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Relevance of nitrosamines to human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Amphiregulin: an early trigger of liver regeneration in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Inflammation and liver cancer: new molecular links .

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The epidermal growth factor receptor: a link between inflammation and liver cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Anthocyanin-rich black currant (Ribes nigrum L.) extract affords chemoprevention against diethylnitrosamine-induced hepatocellular carcinogenesis in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Black currant phytoconstituents exert chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis by suppression of the inflammatory response.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Non-viral causes of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The role of microRNAs in human liver cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The role of cytokines in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

International trends in liver cancer incidence rates

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Cyclooxygenases in hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The protein kinase IKKepsilon regulates energy balance in obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

31 March 2020

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Selenium in the prevention and treatment of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Curcumin and liver cancer: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Hepatic oval cell response to the choline-deficient, ethionine supplemented model of murine liver injury is attenuated by the administration of a cyclo-oxygenase 2 inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Expression of inducible nitric oxide (NO) synthase but not prevention by its gene ablation of hepatocarcinogenesis with fibrosis caused by a choline-deficient, L-amino acid-defined diet in rats and mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Cancer and inflammation: promise for biologic therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Type 2 diabetes as an inflammatory disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

NF-κB and the link between inflammation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Current and future trends in liver transplantation in Europe

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Hepatocellular carcinoma: recent trends in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kappaB activation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Hepatocellular carcinoma pathogenesis: from genes to environment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Risk factors of hepatocellular carcinoma--current status and perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Missing pieces in the NF-kappaB puzzle

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study .

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

MicroRNA involvement in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Inflammatory mechanisms in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Immunity, Inflammation, and Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Essential Role of Matrix Metalloproteinases in Interleukin-1-induced Myofibroblastic Activation of Hepatic Stellate Cell in Collagen

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

A lymphotoxin-driven pathway to hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Chemokines in the immunopathogenesis of hepatitis C infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

NF-κB and STAT3 - key players in liver inflammation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Circuitry of nuclear factor kappaB signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Molecular classification and novel targets in hepatocellular carcinoma: recent advancements

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Chemokines and hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Molecularly targeted therapy in hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

MicroRNA expression, survival, and response to interferon in liver cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

NF-kappaB as a critical link between inflammation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Bioactive food components, inflammatory targets, and cancer prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Oxidative stress increases hepatocyte iNOS gene transcription and promoter activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Molecular approaches to treatment of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The burden of illness associated with hepatocellular carcinoma in the United States.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Sorafenib in advanced hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin-6 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Cancer-related inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Liver inflammation and regeneration: two distinct biological phenomena or parallel pathophysiologic processes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Viral hepatitis and hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

TNP-470 inhibits oxidative stress, nitric oxide production and nuclear factor kappa B activation in a rat model of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Distribution of nitric oxide synthase in normal and cirrhotic human liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

IAP regulation of metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Chemoprevention with phytochemicals targeting inducible nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

NF-kappaB in liver diseases: a target for drug therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Intrinsic apoptosis and NF-κB signaling are potential molecular targets for chemoprevention by black tea polyphenols in HepG2 cells in vitro and in a rat hepatocarcinogenesis model in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Inflammation- and stress-related signaling pathways in hepatocarcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

N-acetylcysteine and S-methylcysteine inhibit MeIQx rat hepatocarcinogenesis in the post-initiation stage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The changing pattern of epidemiology in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Activators and target genes of Rel/NF-kappaB transcription factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The role of STATs in inflammation and inflammatory diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Hepatocellular carcinoma associated with liver-gender disruption in male mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Interaction between interleukin-1beta -31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The Ras inhibitor farnesylthiosalicyclic acid (FTS) prevents nodule formation and development of preneoplastic foci of altered hepatocytes in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Interleukin-6 induces cellular insulin resistance in hepatocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Hepatocellular carcinoma: epidemiology, risk factors, and screening

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Inflammation and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The epidermal growth factor receptor: from development to tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

31 March 2020

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Morin fosters apoptosis in experimental hepatocellular carcinogenesis model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicyclic acid: association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Obesity, inflammation, and liver cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Molecular hepatic carcinogenesis: impact of inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Hepatoprotection via the IL-6/Stat3 pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Roxithromycin inhibits constitutive activation of nuclear factor {kappa}B by diminishing oxidative stress in a rat model of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Intersecting pathways in inflammation and cancer: Hepatocellular carcinoma as a paradigm

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Obesity is associated with macrophage accumulation in adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Recognition and signaling by toll-like receptors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Medical care costs and survival associated with hepatocellular carcinoma among the elderly.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

The role of cyclooxygenases in inflammation, cancer, and development

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

31 March 2020

Liver cancer on the rise

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Regulation of hepatocarcinogenesis by microRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Cyclooxygenase-2 in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

NF-kappaB, an evolutionarily conserved mediator of immune and inflammatory responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

SOCS proteins, cytokine signalling and immune regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

STATs in cancer inflammation and immunity: a leading role for STAT3

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital-treated rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_16

10.1007/978-3-0348-0837-8_16

31 March 2020

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

24818732